v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net loss $ (7,477,000) $ (5,996,000)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 2,274,000 1,876,000
Impairment of property and equipment 666,000  
Stock-based compensation 306,000 57,000
Amortization of debt issuance costs 132,000 97,000
Remeasurement of convertible preferred stock warrant liability 3,725,000 649,000
Loss on early extinguishment of debt 479,000  
Provision for doubtful accounts 140,000  
Changes in operating assets and liabilities:    
Accounts receivable (3,735,000) (1,016,000)
Prepaid expenses and other assets (263,000) (84,000)
Accounts payable 429,000 148,000
Accrued expenses and other current liabilities 486,000 860,000
Deferred revenue 4,398,000 5,152,000
Net cash provided by operating activities 1,560,000 1,743,000
Cash flows from investing activities:    
Purchase of property and equipment (4,547,000) (3,112,000)
Investment in intangible and other assets (55,000) (43,000)
Net cash used in investing activities (4,602,000) (3,155,000)
Cash flows from financing activities:    
Proceeds from initial public offering, net of commissions and discounts 32,426,000  
Proceeds from notes payable 1,500,000 2,000,000
Repayment of notes payable (13,500,000)  
Payment of debt issuance costs (30,000) (17,000)
Payment of debt extinguishment costs (149,000)  
Payments of offering costs (1,858,000)  
Proceeds from exercise of stock options 41,000 21,000
Net cash provided by financing activities 18,430,000 2,004,000
Increase in cash and cash equivalents 15,388,000 592,000
Effect of exchange rate on cash and cash equivalents 2,000 22,000
Cash and cash equivalents at beginning of year 3,865,000 4,124,000
Cash and cash equivalents at end of period 19,255,000 4,738,000
Supplemental cash flow disclosures:    
Cash paid for interest 1,235,000 $ 853,000
Supplemental disclosure of non-cash financing activities:    
Conversion of convertible preferred stock into common stock 42,075,000  
Reclassification of convertible preferred stock warrant liability into additional paid-in capital 5,711,000  
Issuance of warrants in connection with the issuance of notes payable to a financial institution 111,000  
Deferred offering costs included in accounts payable and accruals $ 13,000  

Source